Lead Product(s) : Amiodarone Hydrochloride
Therapeutic Area : Cardiology/Vascular Diseases
Study Phase : Phase I
Sponsor : Helios Cardio
Deal Size : Inapplicable
Deal Type : Inapplicable
Prevention of Postoperative Atrial Fibrillation (POAF) Using Intra-Pericardial Amiodarone
Details : Amiodarone is a Other Small Molecule drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of Atrial Fibrillation.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
October 02, 2023
Lead Product(s) : Amiodarone Hydrochloride
Therapeutic Area : Cardiology/Vascular Diseases
Highest Development Status : Phase I
Sponsor : Helios Cardio
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Amiodarone Hydrochloride
Therapeutic Area : Cardiology/Vascular Diseases
Study Phase : Phase III
Sponsor : Helios Health Institute GmbH | Abbott Laboratories | Center for Clinical Studies Leipzig
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Amiodarone is a Other Small Molecule drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Heart Diseases.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
October 05, 2016
Lead Product(s) : Amiodarone Hydrochloride
Therapeutic Area : Cardiology/Vascular Diseases
Highest Development Status : Phase III
Sponsor : Helios Health Institute GmbH | Abbott Laboratories | Center for Clinical Studies Leipzig
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Amiodarone Hydrochloride
Therapeutic Area : Cardiology/Vascular Diseases
Study Phase : Phase III
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Treatment of Postoperative Atrial Fibrillation - Comparison of Amiodarone and Placebo.
Details : Amiodarone is a Other Small Molecule drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Atrial Fibrillation.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
March 22, 2016
Lead Product(s) : Amiodarone Hydrochloride
Therapeutic Area : Cardiology/Vascular Diseases
Highest Development Status : Phase III
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Amiodarone Hydrochloride
Therapeutic Area : Cardiology/Vascular Diseases
Study Phase : Phase IV
Sponsor : Hamilton Health Sciences
Deal Size : Inapplicable
Deal Type : Inapplicable
AMIOdarone vs. Catheter Ablation for Prevention of Recurrent Symptomatic Atrial Fibrillation
Details : Amiodarone is a Other Small Molecule drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Atrial Fibrillation.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
January 19, 2015
Lead Product(s) : Amiodarone Hydrochloride
Therapeutic Area : Cardiology/Vascular Diseases
Highest Development Status : Phase IV
Sponsor : Hamilton Health Sciences
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Amiodarone Hydrochloride
Therapeutic Area : Cardiology/Vascular Diseases
Study Phase : Undisclosed
Sponsor : Johnson & Johnson
Deal Size : Inapplicable
Deal Type : Inapplicable
INTERVENE: Indian Trial of Endocardial Ventricular Substrate Ablation to Prevent Recurrent VT Events
Details : Amiodarone is a Other Small Molecule drug candidate, which is currently being evaluated in clinical studies for the treatment of Tachycardia, Ventricular.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
November 25, 2014
Lead Product(s) : Amiodarone Hydrochloride
Therapeutic Area : Cardiology/Vascular Diseases
Highest Development Status : Undisclosed
Sponsor : Johnson & Johnson
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Amiodarone Hydrochloride
Therapeutic Area : Cardiology/Vascular Diseases
Study Phase : Phase IV
Sponsor : Medtronic plc | Beijing CTSmed
Deal Size : Inapplicable
Deal Type : Inapplicable
Antiarrhythmic Drugs Assessment in Preventing Atrial Fibrillation
Details : Amiodarone is a Other Small Molecule drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Atrial Fibrillation.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
May 23, 2014
Lead Product(s) : Amiodarone Hydrochloride
Therapeutic Area : Cardiology/Vascular Diseases
Highest Development Status : Phase IV
Sponsor : Medtronic plc | Beijing CTSmed
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Amiodarone Hydrochloride
Therapeutic Area : Cardiology/Vascular Diseases
Study Phase : Undisclosed
Sponsor : Ministry of Health, Brazil | Abbott Laboratories
Deal Size : Inapplicable
Deal Type : Inapplicable
Amiodarone Against ICD Therapy in Chagas Cardiomyopathy for Primary Prevention of Death
Details : Amiodarone HCl is a Other Small Molecule drug candidate, which is currently being evaluated in clinical studies for the treatment of Chagas Cardiomyopathy.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
November 07, 2012
Lead Product(s) : Amiodarone Hydrochloride
Therapeutic Area : Cardiology/Vascular Diseases
Highest Development Status : Undisclosed
Sponsor : Ministry of Health, Brazil | Abbott Laboratories
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Amiodarone Hydrochloride
Therapeutic Area : Cardiology/Vascular Diseases
Study Phase : Undisclosed
Sponsor : Gilead Sciences
Deal Size : Inapplicable
Deal Type : Inapplicable
The Adjunctive Ventricular Arrhythmia Suppression Trial (AVAST) Pilot
Details : Amiodarone is a Other Small Molecule drug candidate, which is currently being evaluated in clinical studies for the treatment of Arrhythmias, Cardiac.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
November 28, 2011
Lead Product(s) : Amiodarone Hydrochloride
Therapeutic Area : Cardiology/Vascular Diseases
Highest Development Status : Undisclosed
Sponsor : Gilead Sciences
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Amiodarone Hydrochloride
Therapeutic Area : Cardiology/Vascular Diseases
Study Phase : Phase III
Sponsor : National Heart, Lung, and Blood Institute | Canadian Institutes of Health Research | Heart and Stroke Foundation | American Heart Association | Defence Research and Development Canada | U.S. Army Medical Research and Development Command
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Amiodarone is a Other Small Molecule drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Heart Arrest.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
July 25, 2011
Lead Product(s) : Amiodarone Hydrochloride
Therapeutic Area : Cardiology/Vascular Diseases
Highest Development Status : Phase III
Sponsor : National Heart, Lung, and Blood Institute | Canadian Institutes of Health Research | Heart and Stroke Foundation | American Heart Association | Defence Research and Development Canada | U.S. Army Medical Research and Development Command
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Amiodarone Hydrochloride
Therapeutic Area : Cardiology/Vascular Diseases
Study Phase : Phase II
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Amiodarone is a Other Small Molecule drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of Atrial Fibrillation.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
October 27, 2010
Lead Product(s) : Amiodarone Hydrochloride
Therapeutic Area : Cardiology/Vascular Diseases
Highest Development Status : Phase II
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Reset All
